Evidence map›Paper›PMID 41560385›Full record

ArticleYonsei medical journal2026

Clinical and Neuroimaging Findings in Patients with Atypical Visual Field Defects.

Na Eun Kim, Jihei Sara Lee, Chan Yun Kim, Hyoung Won Bae

Abstract read
In one paragraph

Article in Yonsei medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Na Eun KimInstitute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-6867-4341
Jihei Sara LeeInstitute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1585-168X
Chan Yun KimInstitute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-8373-9999
Hyoung Won BaeInstitute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea. baekwon@yuhs.ac.ORCID https://orcid.org/0000-0002-8421-5636

Funding

National Research Foundation of Korea 2022R1F1A107625911Samil Pharmaceutical Co., Ltd. 4-2024-0341
6 · The paper itself

Abstract

purposeTo investigate the clinical presentations and neuroimaging findings of patients with atypical visual field defects (VFDs). MATERIALS AND

methodsThis retrospective cross-sectional study included 159 patients who underwent brain magnetic resonance imaging for evaluation of atypical VFDs between 2013 and 2022. Clinical characteristics were compared based on neuroimaging results, and logistic regression was performed to identify independent risk factors for significant findings.

resultsTwenty-nine patients (18.2%) exhibited significant findings responsible for their atypical VFDs, most commonly intracranial tumors and cerebrovascular accidents. Older age [odds ratio (OR) 1.049, 95% confidence interval (CI) 1.018-1.081,

conclusionAtypical VFDs may indicate lesions along the visual pathway. Neuroimaging is recommended for patients with atypical VFDs, particularly those of older age or presenting with decreased visual acuity, rapid progression or incomplete homonymous hemianopsia.

Indexed as

NeuroimagingVision DisordersVisual FieldsAdultAgedCross-Sectional StudiesFemaleHemianopsiaHumansLogistic ModelsMagnetic Resonance ImagingMaleMiddle AgedRetrospective StudiesRisk FactorsVisual Acuityglaucomaneuroimagingoptic neuropathyVisual field defect

Identifiers

PMID41560385
PMCPMC12834608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.